SPP1 is abnormally elevated positively correlated with the severity of tumor malignancy and chemoresistance in breast cancer [9], non-small-cell lung cancer [10], prostate cancer [11], and liver cancer [12]. The gene discussed is SPP1; the disease is neoplasm.